NCT03550976

Brief Summary

The incidence of gestational diabetes increased.The multidisciplinary management of GDM during pregnancy is helpful to improve the pregnancy outcome, but it will occupy huge medical resources.Early prediction, diet and exercise interventions can reduce the incidence of gestational diabetes, but there is no reliable way to predict and intervene early.This study is a randomized controlled trials, and aims to use comprehensive prediction method (genetic screening, body composition, clinical risk factors screening) screening the subjects with high GDM risk in early pregnancy, conducting diet and exercise intervention in second trimester and observing the effect on the incidence of GDM and perinatal outcomes.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 29, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 11, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

August 8, 2018

Status Verified

August 1, 2018

Enrollment Period

11 months

First QC Date

May 29, 2018

Last Update Submit

August 6, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of gestational diabetes

    The incidence of GDM was compared between the low-GI diet and the muscle training group, the high-risk control group and the low-risk control group.

    12-28 weeks of pregnancy

Study Arms (3)

High risk intervention group

EXPERIMENTAL
Behavioral: The low-GI diet and muscle training

High risk control group

NO INTERVENTION

Dietary evaluation and body composition analysis at 12 and 28 weeks of pregnancy. Receive routine obstetric examinations and routine health education which includes proper diet and exercise advice.Collect birth outcomes.

Low risk control group

NO INTERVENTION

Dietary evaluation and body composition analysis at 12 and 28 weeks of pregnancy. Receive routine obstetric examinations and routine health education which includes proper diet and exercise advice.Collect birth outcomes.

Interventions

During the 12-28 weeks of pregnancy, the pregnant women received low-GI diet and exercise intervention.Every two weeks, the pregnant women were followed up to assess the dietary situation and analyze the body composition results.Collect birth outcomes

High risk intervention group

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • early pregnant women (\< 12 weeks)
  • fasting blood glucose \< / = 5.6 mmol/L and glycosylated hemoglobin \< / = 5.6%
  • prepregnancy overweight (BMI \> 23.9) or body fat content more than 30% (based on body composition analysis)
  • no history of major diseases or long-term drug treatment
  • no obvious physical disabilities, the ability of physical activity is normal
  • dietary behavior and mental is normal
  • resident in Beijing, early and middle stage pregnancy can be in Beijing area to receive regular obstetric examinations
  • signed informed consent
  • the following at least one
  • first-degree relatives family history of diabetes
  • history of abnormal lipid metabolism or abnormal lipid metabolism
  • history of polycystic ovary syndrome
  • history of large for gestational age infant or macrosomia deliver

You may not qualify if:

  • history of gestational diabetes mellitus
  • clinical glucose metabolism abnormalities
  • once taking diabetes drugs or insulin injections
  • a variety of food allergies or food choices serious limitations
  • exercise during pregnancy contraindication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Yanpin Liu, bachelor

CONTACT

Yixuan Hou, master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

May 29, 2018

First Posted

June 11, 2018

Study Start

October 1, 2018

Primary Completion

September 10, 2019

Study Completion

June 1, 2020

Last Updated

August 8, 2018

Record last verified: 2018-08